Recent studies show that c-Abl activation occurs in PD pathophysiology through the direct phosphorylation of α-synuclein, facilitating its accumulation and impeding its clearance by the ubiquitin-proteasome system [224]. Here, ABL1 is linked to Parkinson disease.